DARBID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Darbid, and what generic alternatives are available?
Darbid is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in DARBID is isopropamide iodide. There are two drug master file entries for this compound. Additional details are available on the isopropamide iodide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DARBID?
- What are the global sales for DARBID?
- What is Average Wholesale Price for DARBID?
Summary for DARBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Patent Applications: | 1,122 |
| DailyMed Link: | DARBID at DailyMed |
US Patents and Regulatory Information for DARBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | DARBID | isopropamide iodide | TABLET;ORAL | 010744-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
